CTRI/2023/07/055127Not yet recruitingPhase 3
Evaluation of Efficacy of ashwagandadi guggulu and simhanada guggulu with erandamooladi kshara basti and valuka sweda in Amavata vis-a-vis Rheumatoid arthritic An open label randomized comparative clinical study - NI
Dr Venkatesh R0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Subjects who fulfil diagnostic criteria of Amavata & Rheumatoid arthritis, irrespective of gender, religion, occupation and socio-economic status.
- •Age group between 18-60years, fit for Basti and willing to sign informed consent.
- •Diagnosed cases of Rheumatoid arthritis, with or without conventional medication.
Exclusion Criteria
- •Subjects with other systemic diseases which would interfere the present study such as Diabetes mellitus, CAD,CKD.
- •Subjects who have developed other connective tissue disorders or any Autoimmune disorder such as Osteoarthritis, SLE, Gouty Arthritis.
- •Pregnant women and Lactating mother.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
AYURVEDIC TREATMENT OF ACIDITYCTRI/2022/01/039311PT KHUSHILAL SHARMA GOVERNMENT AUTONOMOUS AYURVEDA COLLEGE AND INSTITUTE BHOPAL MP
Completed
Phase 2
The effect of Ashwagandhadi granules (Ayurveda formulation) for health promotioCTRI/2020/12/029595Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan46
Completed
Phase 2
to compare the efficiency of some herbal drugs in the treatment of amavataCTRI/2017/12/010844ational Institute of Ayurved50
Not yet recruiting
Phase 2
TO STUDY OF EFFECT OF AMRITA GUGGULU, RASNASAPTAKA KWATHA AND RUKSHA SWEDA IN THE TREATMENT OF AMAVATA( RHEUMATOID ARTHRITIS).CTRI/2018/10/016096ational Institute Of Ayurveda Jaipur Rajsthan
Completed
Phase 2
Evaluate the efficacy of Kaishora Guggulu with and withoutVirechana Karma in the management of Vatarakta (Gout)CTRI/2021/03/032128All India Institute of Ayurveda30